OnabotulinumtoxinA Bladder Injection Study

Clinical trial NCT03523091 · TERMINATED

Trial details

NCT number: NCT03523091
Sponsor: Corewell Health East
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Overactive Bladder Overactive Bladder Syndrome Urinary Urgency Urinary Incontinence Urinary Frequency/Urgency Urinary Bladder, Overactive

Start date: 2018-08-08
Primary completion: 2020-09-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.